Trullàs, Joan Carles
Casado, Jesús
Cobo-Marcos, Marta
Formiga, Francesc
Morales-Rull, José Luís
Núñez, Julio
Manzano, Luís
Article History
Accepted: 20 March 2024
First Online: 9 April 2024
Declarations
:
: JC received consulting and lecture fees from AstraZeneca, Boehringer Ingelheim, Novartis and Vifor Pharma (outside the submitted work). MCM reports personal fees or advisory boards from AstraZeneca, Boehringer Ingelheim, Bayer, Novartis, NovoNordisk, Rovi, and Vifor Pharma (outside the submitted work). JLMR received consulting and lecture fees from AstraZeneca, Boehringer Ingelheim, Esteve and Zambon. JN reports personal fees or advisory boards from Alleviant, AstraZeneca, Boehringer Ingelheim, Bayer, Novartis, NovoNordisk, Pfizer, Rovi, and Vifor Pharma (outside the submitted work). LM reports personal fees or advisory boards from AstraZeneca, Boehringer Ingelheim, Lilly, Bayer, Novartis and Rovi (outside the submitted work). JCT and FF declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.